Ray Dalio started to build up the position in Novavax in Q3 2021 and continued to invest until Q2 2022. Since then they sold 35.4 Thousand shares. The investor sold all their shares in Q3 2022 and doesn't own any shares in Novavax anymore.
Avg closing price
Price range
Sold -35.4 Thousand shares
Q3 2022
Avg closing price
$43.33
Price range
$18.20
-
$76.12
Increased shares by 779.3% (+31.3 Thousand shares)
Q2 2022
Avg closing price
$51.80
Price range
$36.28
-
$75.29
Increased shares by 64.8% (+1.58 Thousand shares)
Q1 2022
Avg closing price
$89.17
Price range
$69.73
-
$142.90
Increased shares by 114.6% (+1.3 Thousand shares)
Q4 2021